BUSINESS NEWS

Copy Carman McNary elected Chair of Canadian Chamber of Commerce· Canadian Chamber of Commerce Fiscal and monetary policy are not at odds, Bank of Canada's Macklem tells MPs· BNN Bloomberg Canadian economy stalled in August, points to September decline: StatsCan· CBC How one Canadian company’s move to Texas reflects economic pressures facing Canadian businesses - Radio-Canada Recent developments in the Canadian economy: Fall 2026· Statistique Canada Higher fuel costs and tariffs expected to slow Canadian economy· DiscoverMooseJaw Q3-26 Canadian Business Outlook Survey: More firms plan cost pass-through· RBC Canada’s economy expected to slow in fourth quarter· Consulting.ca Posthaste: U.S. businesses feel fresh pain from trade war with Canada, says this hot take on the economy· Financial Post Canadian businesses calling for tax reform, less red tape in federal budget· BNN Bloomberg Opinion: If Canada’s population isn’t shrinking, our economic numbers aren’t so good after all· The Globe and Mail Canada's next budget to be unveiled this week amid U.S. trade war, economic uncertainty· CBC Canada weathered the first tariff shocks. But Deloitte sees trouble ahead· National Post Canada–Latin America Trade and Investment: Emerging Opportunities in a Changing Global Economy· McMillan LLP Growing the Oil and Gas Sector Helps Grow Canada’s Economy· Canadian Chamber of Commerce

← All tenders

Department of Public Works and Government Services (PSPC)

ACAN Vaccinia Immunoglobulin intravenous (human) - VIGIV

Name: ACAN Vaccinia Immunoglobulin intravenous (human) - VIGIV
Creator: Department of Public Works and Government Services (PSPC)

Advance Contract Award Notice (ACAN)

Estimated value

Not disclosed

Deadline

September 30, 2026

Published

September 10, 2026

Type

Goods

Full description

Advanced Contract Award Notice(ACAN) - Vaccinia Immunoglobulin intravenous (human) (VIGIV)
An ACAN is a public notice indicating to the supplier community that a department or agency intends to award a contract for goods, services or construction to a pre-identified supplier, thereby allowing other suppliers to signal their interest in bidding, by submitting a statement of capabilities. If no supplier submits a statement of capabilities that meets the requirements set out in the ACAN, on or before the closing date stated in the ACAN, the contracting officer may then proceed with the award to the pre identified supplier.
Purpose of this Advanced Contract Award Notice (ACAN):
Public Services and Procurement Canada proposes to negotiate a contract with Emergent BioSolutions Canada Inc on behalf of Public Health Agency of Canada (PHAC).
Requirement description:
Public Health Agency of Canada (PHAC) has a requirement for vaccinia Immunoglobulin intravenous (human) (VIGIV) to protect against complications from vaccination with live-replicating smallpox vaccines containing vaccinia virus.

Selection criteria

Not applicable

AI Summary

Advanced Contract Award Notice(ACAN) - Vaccinia Immunoglobulin intravenous (human) (VIGIV) An ACAN is a public notice indicating to the supplier community that a department or agen...

Intended sole-source award

The buyer plans to award this contract to a named supplier without competition. If your business can do this work, send a statement of capabilities to the contracting authority before September 30, 2026. If it qualifies, the buyer must open a full competition.

AI Analysis

Get a plain-English breakdown of this tender — what they need, who can bid, how to approach it, and tips for small suppliers. Takes a couple of seconds.

Basic information

Reference

WS5872093541-Doc5872241906

Solicitation no.

WS5872093541

Buyer

Department of Public Works and Government Services (PSPC)

Notice type

Advance Contract Award Notice

Method

Advance contract award notice

Procurement category

*GD

Trade agreements

*World Trade Organization Agreement on Government Procurement (WTO GPA) *Canada-Chile Free Trade Agreement (CCFTA) *Canada-Korea Free Trade Agreement (CKFTA) *Canada-Ukraine Free Trade Agreement (CUFTA) *Canada-European Union Comprehensive Economic and Trade Agreement (CETA) *Canada-Panama Free Trade Agreement *Canada-Honduras Free Trade Agreement *Canadian Free Trade Agreement (CFTA) *Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP) *Canada-Peru Free Trade Agreement (CPFTA) *Canada-UK Trade Continuity Agreement (Canada-UK TCA) *Canada-Colombia Free Trade Agreement

Estimated value

Not disclosed

Source

canadabuys

Classification & terms

UNSPSC

UNSPSC 51000000 — Drugs and Pharmaceutical Products

Limited tendering reason

Exclusive Rights

Delivery & regions

Province

Quebec

Regions of delivery

*Canada

Key dates

Published

September 10, 2026

Closes

September 30, 2026

Amendment no.

000

Amendment date

September 10, 2026

Contact

Contact

R••••••••, A••• (S•••/P•••)

Email

a••••••••@••••••••.••.ca

Address

•• ••••••• ••, ••••• •••, ••••• •• •••••••, ••••••••, ••••••, ••• •••, ••••••

End-user

Public Health Agency of Canada (PHAC)

Award history

0 past awards in this classification and 5 likely incumbents from this buyer. Pro shows who won and for how much.

Upgrade to Pro

Complete source record(28)

Title

ACAN Vaccinia Immunoglobulin intravenous (human) - VIGIV

Reference number

WS5872093541-Doc5872241906

Amendment number

000

Solicitation number

WS5872093541

Publication date

2026-09-10

Tender closing date

2026-09-30T14:00:00

Amendment date

2026-09-10

Tender status

Open

Unspsc

*51000000

Unspsc description

*Drugs and Pharmaceutical Products

Procurement category

*GD

Notice type

Advance Contract Award Notice

Procurement method

Advance contract award notice

Selection criteria

Not applicable

Limited tendering reason

Exclusive Rights

Trade agreements

Regions of delivery

*Canada

Contracting entity name

Department of Public Works and Government Services (PSPC)

Contracting entity address line

11 Laurier St, Phase III, Place du Portage

Contracting entity address city

Gatineau

Contracting entity address province

Quebec

Contracting entity address postal code

K1A 0S5

Contracting entity address country

Canada

End user entities name

Public Health Agency of Canada (PHAC)

End user entities address

130 Colonnade Road,Ottawa,Ontario,K1A 0K9,Canada

Contact info name

R••••••••, A••• (S•••/P•••)

Contact info email

a••••••••@••••••••.••.ca

Tender description

Advanced Contract Award Notice(ACAN) - Vaccinia Immunoglobulin intravenous (human) (VIGIV) An ACAN is a public notice indicating to the supplier community that a department or agency intends to award a contract for goods, services or construction to a pre-identified supplier, thereby allowing other suppliers to signal their interest in bidding, by submitting a statement of capabilities. If no supplier submits a statement of capabilities that meets the requirements set out in the ACAN, on or before the closing date stated in the ACAN, the contracting officer may then proceed with the award to the pre identified supplier. Purpose of this Advanced Contract Award Notice (ACAN): Public Services and Procurement Canada proposes to negotiate a contract with Emergent BioSolutions Canada Inc on behalf of Public Health Agency of Canada (PHAC). Requirement description: Public Health Agency of Canada (PHAC) has a requirement for vaccinia Immunoglobulin intravenous (human) (VIGIV) to protect against complications from vaccination with live-replicating smallpox vaccines containing vaccinia virus.